Feature Channels:

Alzheimer's and Dementia

Add to Favorites | Subscribe | Share

Filters:

  • (Press "esc" to clear)

Medicine

Channels:

University of Rhode Island Group Takes Holistic Look at Lifestyle and Dementia

Faculty, staff and graduate students are taking on one of society’s most vexing health challenges: how to prevent or slow the onset of dementia through changes in diet and exercise. And what sets the Lifestyle Interventions Group apart is its inclusion of disciplines beyond the typical confines of brain science.

Medicine

Channels:

New Technology Aims to Provide Peace and Positive Stimulation to Dementia Patients

Patients can engage with the Ambient Activity Technology device any time to view family photos, hear their favorite music, and play games.

Medicine

Channels:

Icahn School of Medicine at Mount Sinai, The Mount Sinai Hospital, Mount Sinai Health System, myeloid cells, alzhiemer's disease, Alzheimer's Disease, Epigenetic, epigenetic alterations, APOE, PU.1, late-onset form, brain networks, Microglia, Macrophage, phagocytic activity

Risk of Developing Alzheimer’s Disease Linked to a Network of Genes Associated with Myeloid Cells

Mount Sinai researchers find this network central to Alzheimer’s disease susceptibility

Medicine

Channels:

Alzheimber's Disease, Beth Israel Deaconess Medical Center, Neuroscience

Anti-Epilepsy Drug Restores Normal Brain Activity in Mild Alzheimer’s Disease

In a recent feasibility study, BIDMC tested an anti-epileptic drug for its potential impact on the brain activity of patients with mild Alzheimer’s disease. The team documented changes in patients’ EEGs that suggest the drug could have a beneficial effect.

Medicine

Channels:

Cardiovascular Disease, Hypertension, Dementia, Elderly, Behavioral Activation

Leisure Activities Lower Blood Pressure in Alzheimer’s Caregivers

Going for a walk outside, reading, listening to music—these and other enjoyable activities can reduce blood pressure for elderly caregivers of spouses with Alzheimer’s disease, suggests a study in Psychosomatic Medicine: Journal of Biobehavioral Medicine, the official journal of the American Psychosomatic Society. The journal is published by Wolters Kluwer.

Medicine

Channels:

Study Shows Seniors with Dementia Are on the Rise

Study shows seniors with dementia are on the rise. Dr. Yves Joanette is available to speak about the disease.

Medicine

Channels:

alzheimer disease, Alzheimer Disease & Associated Disorders, Parkinson Disease, Lewy Body Dementia, Lewy Bodies, Dementia, Preventive Medicine, Neuroscience, Baby Boomers, Aging and Disease, health and wellness

FAU Launches Unique Dementia Prevention Program and Center

Is it possible to prevent dementia from happening in the first place? That’s what a leading FAU neuroscientist plans to prove using an innovative approach that defies the idea that “one-size-fits-all” when it comes to battling Alzheimer’s disease, Lewy Body Dementia, Parkinson’s disease and other related disorders. Using a personalized approach and precision medicine to reduce risk, this center is one of only a handful of centers in the world that focuses on dementia prevention.

Medicine

Channels:

Temple, Temple University, Temple University Hospital, Hospital, olive oil health effects, Olive Oil, Alzheimer's Disease, Alzheimer's Association International Conference, Alzheimer's, Brain, Research

Extra-Virgin Olive Oil Preserves Memory and Protects Brain Against Alzheimer's Disease, New Research at Temple Shows

The Mediterranean diet, rich in plant-based foods, is associated with a variety of health benefits, including a lower incidence of dementia.

Medicine

Channels:

Alzheimer's Disease, Microglia, Genetics, Immune Cell

A Single Microglial Protein Controls Suite of Alzheimer’s Risk Genes

The discovery hints that microglia, rather than neurons, may control much of a person’s genetic susceptibility to Alzheimer’s disease.

Medicine

Channels:

Scripps Florida Scientist and Collaborators Win $7 Million Grant to Develop New ALS Treatments

disney_matthew.jpg

Professor Matthew Disney of the Department of Chemistry on the Florida campus of The Scripps Research Institute (TSRI), together with scientists from Mayo Clinic’s Florida campus and Johns Hopkins School of Medicine, has been awarded $7.2 million from the National Institute of Neurological Disorders and Stroke of The National Institutes of Health to create new RNA-based treatments for the most common form of amyotrophic lateral sclerosis (ALS), as well as a type of frontotemporal dementia (FTD).







Chat now!